Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project
暂无分享,去创建一个
U. Walter | P. Wild | K. Lackner | T. Münzel | J. Prochaska | V. Grossmann | S. Konstantinides | A. Ullmann | G. Weisser | H. Lamparter | Liana Ariza | C. Espinola-Klein | Bernd Frank | Florentina Kindler | Heidrun Lamparter | Alexander Ullmann
[1] S. Schulman,et al. Management of venous thromboembolism: an update , 2016, Thrombosis Journal.
[2] P. Wild,et al. Evaluation of oral anticoagulation therapy: Rationale and design of the thrombEVAL study programme , 2015, European journal of preventive cardiology.
[3] Amani A. Osman,et al. Comprehensive study on laboratory biomarkers for prediction and diagnosis of deep venous thrombosis , 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[4] E. V. de Paula,et al. Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis. , 2015, Thrombosis research.
[5] M. Cushman,et al. Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post‐thrombotic syndrome , 2015, Journal of thrombosis and haemostasis : JTH.
[6] J. Ferreira,et al. Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis , 2015, Journal of Neurology.
[7] Jose Luis Zamorano,et al. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .
[8] Adam Torbicki,et al. Management of venous thrombo-embolism: an update. , 2014, European heart journal.
[9] L. Quan,et al. The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human atherosclerotic coronary artery. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[10] M. Revel,et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism , 2014, Thrombosis and Haemostasis.
[11] S. Imfeld,et al. Phase III Trials of New Oral Anticoagulants in the Acute Treatment and Secondary Prevention of VTE: Comparison and Critique of Study Methodology and Results , 2014, Advances in Therapy.
[12] J. Sundquist,et al. Familial Transmission of Venous Thromboembolism: A Cohort Study of 80 214 Swedish Adoptees Linked to Their Biological and Adoptive Parents , 2014, Circulation. Cardiovascular genetics.
[13] M. Monreal,et al. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs. , 2014, Journal of Vascular Surgery.
[14] C. Martinez,et al. Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer , 2014, Thrombosis and Haemostasis.
[15] Talicia Tarver,et al. HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .
[16] E. Akl,et al. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. , 2014, Blood.
[17] P. Wells,et al. Treatment of venous thromboembolism. , 2014, JAMA.
[18] S. Goldhaber,et al. Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis , 2014, Circulation.
[19] P. Wells,et al. The diagnosis and treatment of venous thromboembolism. , 2013, Hematology. American Society of Hematology. Education Program.
[20] M. Crowther,et al. Treatment with novel oral anticoagulants: indications, efficacy and risks , 2013, Current opinion in hematology.
[21] D. Poli,et al. Assessing recurrence risk following acute venous thromboembolism: use of algorithms , 2013, Current opinion in pulmonary medicine.
[22] Giancarlo Agnelli,et al. Oral apixaban for the treatment of acute venous thromboembolism. , 2013, The New England journal of medicine.
[23] S. Greco,et al. Oxidative Stress and MicroRNAs in Vascular Diseases , 2013, International journal of molecular sciences.
[24] G. Raskob,et al. Edoxaban for the long‐term treatment of venous thromboembolism: rationale and design of the Hokusai‐venous thromboembolism study – methodological implications for clinical trials , 2013, Journal of thrombosis and haemostasis : JTH.
[25] K. Guire,et al. Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis. , 2013, Journal of vascular surgery. Venous and lymphatic disorders.
[26] S. Ozsu,et al. Chronic thromboembolic pulmonary hypertension: Medical treatment , 2013, Pulmonary circulation.
[27] M. Sartori,et al. The Wells rule and D‐dimer for the diagnosis of isolated distal deep vein thrombosis , 2012, Journal of thrombosis and haemostasis : JTH.
[28] P. Prandoni. Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study , 2012, European journal of haematology.
[29] D. Lamping,et al. The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients , 2012, Health and Quality of Life Outcomes.
[30] M. Wetherill,et al. Implementing NICE guidelines on risk assessment for venous thromboembolism: failure, success and controversy. , 2012, International journal of health care quality assurance.
[31] Junjie Xiao,et al. Circulating microRNAs: novel biomarkers for cardiovascular diseases , 2012, Journal of Molecular Medicine.
[32] M. Blettner,et al. Die Gutenberg Gesundheitsstudie , 2012, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[33] W. Olson,et al. All-Cause and Potentially Disease-Related Health Care Costs Associated with Venous Thromboembolism in Commercial, Medicare, and Medicaid Beneficiaries , 2012, Journal of managed care pharmacy : JMCP.
[34] D. Shi,et al. Biomarkers of deep venous thrombosis , 2012, Journal of Thrombosis and Thrombolysis.
[35] Mitsuo Kato,et al. Pro-Inflammatory Role of MicroRNA-200 in Vascular Smooth Muscle Cells From Diabetic Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[36] Paolo Prandoni,et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[37] Gordon H Guyatt,et al. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[38] M. Schindewolf,et al. Performance of five D-dimer assays for the exclusion of symptomatic distal leg vein thrombosis , 2012, Thrombosis and Haemostasis.
[39] K. Guire,et al. Evaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[40] C. Meisinger,et al. Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg Study. , 2011, Clinical chemistry.
[41] D. Tregouet,et al. Lessons from genome‐wide association studies in venous thrombosis , 2011, Journal of thrombosis and haemostasis : JTH.
[42] P. Fasanaro,et al. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition , 2011, Cell Death and Differentiation.
[43] K. Moons,et al. Systematic review: Diagnostic accuracy of clinical decision rules for venous thromboembolism in elderly , 2011, Ageing Research Reviews.
[44] R. Gans,et al. Oral rivaroxaban for symptomatic venous thromboembolism. , 2011, The New England journal of medicine.
[45] Bruce L Davidson,et al. Oral rivaroxaban for symptomatic venous thromboembolism. , 2010, The New England journal of medicine.
[46] O. Dekkers,et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study , 2011, Journal of thrombosis and haemostasis : JTH.
[47] B. Nordestgaard,et al. C-Reactive Protein and Risk of Venous Thromboembolism in the General Population , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[48] J. Strahler,et al. Proteomics of microparticles after deep venous thrombosis. , 2010, Thrombosis research.
[49] C. Fox,et al. Relations of Insulin Resistance and Glycemic Abnormalities to Cardiovascular Magnetic Resonance Measures of Cardiac Structure and Function: The Framingham Heart Study , 2010, Circulation. Cardiovascular imaging.
[50] Rüdiger Zwerenz,et al. Screening nach Depersonalisation-Derealisation mittels zweier Items der Cambridge Depersonalisation Scale , 2009, Psychotherapie, Psychosomatik, medizinische Psychologie.
[51] C. Esmon,et al. Inflammation, innate immunity and blood coagulation , 2010, Hämostaseologie.
[52] H. Büller,et al. Quality of life after pulmonary embolism: validation of the PEmb‐QoL Questionnaire , 2010, Journal of thrombosis and haemostasis : JTH.
[53] A. Folsom,et al. C-reactive protein and venous thromboembolism , 2009, Thrombosis and Haemostasis.
[54] Piotr Pruszczyk,et al. Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .
[55] S. Kahn,et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy , 2008, Canadian Medical Association Journal.
[56] E. Oger,et al. Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.
[57] Patrick Monahan,et al. Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection , 2007, Annals of Internal Medicine.
[58] Vittorio Pengo,et al. Chronic thromboembolic pulmonary hypertension. , 2006, Journal of the American College of Cardiology.
[59] A J Sutton,et al. Variation in the diagnostic performance of D-dimer for suspected deep vein thrombosis. , 2005, QJM : monthly journal of the Association of Physicians.
[60] B. Kudielka,et al. [Evaluation of the German Type D Scale (DS14) and prevalence of the Type D personality pattern in cardiological and psychosomatic patients and healthy subjects]. , 2004, Psychotherapie, Psychosomatik, medizinische Psychologie.
[61] Paolo Prandoni,et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.
[62] W. Saris,et al. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. , 2003, Journal of clinical epidemiology.
[63] John A. Heit,et al. The epidemiology of venous thromboembolism , 2003, Journal of Thrombosis and Thrombolysis.
[64] R. Bucek,et al. C‐reactive protein in the diagnosis of deep vein thrombosis , 2002, British journal of haematology.
[65] R. Spitzer,et al. The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms , 2002, Psychosomatic medicine.
[66] J. Denollet. Personality and coronary heart disease: The type-D scale-16 (DS16) , 1998, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[67] W M O'Fallon,et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.
[68] Janis Bormanis,et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management , 1997, The Lancet.
[69] C. Mannhalter. Biomarkers for arterial and venous thrombotic disorders , 2014, Hämostaseologie.
[70] M. Humbert,et al. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .
[71] M Blettner,et al. [The Gutenberg Health Study]. , 2012, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.
[72] W. Auger,et al. Chronic thromboembolic pulmonary hypertension. , 2009, Seminars in respiratory and critical care medicine.
[73] U. John,et al. Distribution and dose response of laboratory markers to alcohol consumption in a general population: results of the study of health in Pomerania (SHIP). , 2003, Journal of studies on alcohol.
[74] J. Davidson,et al. Mini‐SPIN: A brief screening assessment for generalized social anxiety disorder , 2001, Depression and anxiety.
[75] R. Spitzer,et al. The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.
[76] M Gent,et al. Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer , 2000, Thrombosis and Haemostasis.
[77] H. Büller,et al. Diagnosis of recurrent deep vein thrombosis. , 1995, Haemostasis.